S&P 500, Dow hit record highs on vaccine optimism

By: |
November 9, 2020 9:10 PM

The S&P 500 and Dow hit record highs moments after the open on Monday, as news of the first successful late stage COVID-19 vaccine trials stirred hopes of the economy emerging from a year of pandemic-driven crisis.

RIL, bharti airtelOverhangs on the sector’s performance now seem to have reduced and with the preliminary recovery in economic indicators the outlook is now better than where it was a few months back.

The S&P 500 and Dow hit record highs moments after the open on Monday, as news of the first successful late stage COVID-19 vaccine trials stirred hopes of the economy emerging from a year of pandemic-driven crisis.

The Dow Jones Industrial Average rose 1,144.50 points, or 4.04%, at the open to 29,467.90.

The S&P 500 opened higher by 73.60 points, or 2.10%, at 3,583.04, while the Nasdaq Composite gained 151.43 points, or 1.27%, to 12,046.66 at the opening bell.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Reliance leads 10 most valued firms to lose Rs 91,699 cr in m-cap
2FPIs net buyers for 2nd consecutive month in Nov, invest record sum of Rs 60,358 cr in equities
3Companies raise Rs 25,000 cr via IPOs in 2020 so far; next year expected to be equally strong